ONC - BeiGene gets EU backing for neck and head cancer treatment
2025-05-27 09:06:12 ET
More on BeiGene
- BeiGene, Ltd., Soon To Be BeOne Medicines: New Name And New Profit
- BeiGene, Ltd. (ONC) Q1 2025 Earnings Call Transcript
- BeiGene: Q4 Results Impress With Positive Earnings Expected In 2025
- Drugmakers rebound after White House eases fears over Trump’s drug pricing order
- BeiGene targets $4.9B-$5.3B revenue for 2025 with strong BRUKINSA and pipeline growth